Exane Derivatives’s Starbucks SBUX Stock Holding History
Bought
Maintained
Sold
Other funds holding SBUX
MAM
Exane Derivatives's SBUX Position: Q4 2021 in Review
Exane Derivatives sold out of Starbucks (SBUX) in Q4 2021, closing a stake of 2,667 shares — an estimated $294K sold.
Exane Derivatives first reported a position in SBUX in Q4 2014 and held it in 28 quarters. The position peaked at $1.47M in Q1 2019. 2,412 funds tracked by Wall St. Rank hold SBUX as of Q4 2021.
- Exane Derivatives reported no remaining Starbucks position as of Q4 2021 after selling out during the quarter.
- Exane Derivatives sold 2,667 Starbucks shares in Q4 2021, an estimated $294K.
- Exane Derivatives first reported a position in Starbucks in Q4 2014 and held it in 28 quarters.
- Exane Derivatives's Starbucks position peaked at $1.47M in Q1 2019.
- 2,412 funds tracked by Wall St. Rank held Starbucks as of Q4 2021.
Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.